NEUROMIDIN PILLS 20MG

Pills

Composition

1 pill contains ipidacrine 20 mg

Packaging

50 pcs.

Mechanism of action

Neuromidin has anticholinesterase effect.

Peripheral nervous system diseases:
- Neuritis.
- Polyneuritis.
- polyneuropathy.
- Polyradiculopathy.
- Myasthenia.
- Myasthenic syndrome of different etiology.

Contraindications

- Epilepsy.
- Vestibular disorders.
- Extrapyramidal diseases with hyperkinesis.
- Angina pectoris.
- Severe bradycardia.
- Bronchial asthma.
- Peptic ulcer of the stomach or duodenum in the acute phase.
- Obstruction of the intestine or urinary tract.
- Pregnancy.
- Lactation period (breastfeeding).
- Childhood.
- Hypersensitivity to the drug.

Use with caution in the following cases:

- Peptic ulcer of the stomach and duodenum.
- Thyrotoxicosis.
- Diseases of the cardiovascular system.
- Obstructive diseases of the respiratory system in history or in acute diseases of the respiratory tract.

Special notes

During treatment, one should refrain from driving a car, as well as practicing potentially hazardous activities that require increased concentration and psychomotor speed.

Drug Interactions

Neuromidin enhances sedation in combination with CNS depressants.

The effect of the drug and side effects are enhanced when combined with other cholinesterase inhibitors and m-cholinomimetic agents.

In patients with myasthenia, the risk of a cholinergic crisis is increased, while the use of Neuromidin with other cholinergic agents.

The risk of developing bradycardia increases if beta-blockers are used prior to the initiation of treatment with Neuromidin.

The drug can be used in combination with Cerebrolysin.

Ethanol enhances the side effects of the drug.

Neuromidine, when administered orally, weakens the inhibitory effect on the neuromuscular transmission and conduction of excitation along the peripheral nerves of local anesthetics, aminoglycosides, potassium chloride.

Overdosage

If poisoning Neuromidin immediately cause vracha.Simptomy: loss of appetite, bronchospasm, lacrimation, sweating, pupillary constriction, nystagmus, increased gastrointestinal motility, spontaneous defecation and urination, vomiting, jaundice, bradycardia, impaired intracardiac conduction, arrhythmias, blood pressure reduction, anxiety, anxiety, agitation, fear, ataxia, convulsions, coma, speech disorders, drowsiness, general weakness.
Treatment: gastric lavage, use of m-cholinoblockers (including atropine, cyclodol, metacin), symptomatic therapy.

The drug should be stored in a dry, dark place at a temperature not higher than 25 ° C.